Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target von Timmerman, Luika A., Holton, Thomas, Yuneva, Mariia, Louie, Raymond J., Padró, Mercè, Daemen, Anneleen, Hu, Min, Chan, Denise A., Ethier, Stephen P., van ‘t Veer, Laura J., Polyak, Kornelia, McCormick, Frank, Gray, Joe W.

Volltext

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies von Wolf, Denise M., Yau, Christina, Wulfkuhle, Julia, Brown-Swigart, Lamorna, Gallagher, Rosa I., Lee, Pei Rong Evelyn, Zhu, Zelos, Magbanua, Mark J., Sayaman, Rosalyn, O’Grady, Nicholas, Basu, Amrita, Delson, Amy, Coppé, Jean Philippe, Lu, Ruixiao, Braun, Jerome, Asare, Smita M., Sit, Laura, Matthews, Jeffrey B., Perlmutter, Jane, Hylton, Nola, Liu, Minetta C., Pohlmann, Paula, Symmans, W. Fraser, Rugo, Hope S., Isaacs, Claudine, DeMichele, Angela M., Yee, Douglas, Berry, Donald A., Pusztai, Lajos, Petricoin, Emanuel F., Hirst, Gillian L., Esserman, Laura J., van 't Veer, Laura J.

Volltext

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance von Stejskal, Pavel, Goodarzi, Hani, Srovnal, Josef, Hajdúch, Marián, van 't Veer, Laura J, Magbanua, Mark Jesus M

Volltext

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer von Lee, Joyce V., Housley, Filomena, Yau, Christina, Nakagawa, Rachel, Winkler, Juliane, Anttila, Johanna M., Munne, Pauliina M., Savelius, Mariel, Houlahan, Kathleen E., Van de Mark, Daniel, Hemmati, Golzar, Hernandez, Grace A., Zhang, Yibing, Samson, Susan, Baas, Carole, Kok, Marleen, Esserman, Laura J., van ‘t Veer, Laura J., Rugo, Hope S., Curtis, Christina, Klefström, Juha, Matloubian, Mehrdad, Goga, Andrei

Volltext

Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity von Wolf, Denise M, Lenburg, Marc E, Yau, Christina, Boudreau, Aaron, van 't Veer, Laura J

Volltext

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age von Piccart, Martine, van 't Veer, Laura J, Poncet, Coralie, Lopes Cardozo, Josephine M N, Delaloge, Suzette, Pierga, Jean-Yves, Vuylsteke, Peter, Brain, Etienne, Vrijaldenhoven, Suzan, Neijenhuis, Peter A, Causeret, Sylvian, Smilde, Tineke J, Viale, Giuseppe, Glas, Annuska M, Delorenzi, Mauro, Sotiriou, Christos, Rubio, Isabel T, Kümmel, Sherko, Zoppoli, Gabriele, Thompson, Alastair M, Matos, Erika, Zaman, Khalil, Hilbers, Florentine, Fumagalli, Debora, Ravdin, Peter, Knox, Susan, Tryfonidis, Konstantinos, Peric, Aleksandra, Meulemans, Bart, Bogaerts, Jan, Cardoso, Fatima, Rutgers, Emiel J T

Volltext

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis von van den Broek, Alexandra J, Schmidt, Marjanka K, van 't Veer, Laura J, Tollenaar, Rob A E M, van Leeuwen, Flora E

Volltext

Complex landscapes of somatic rearrangement in human breast cancer genomes von Stephens, Philip J., McBride, David J., Lin, Meng-Lay, Varela, Ignacio, Pleasance, Erin D., Simpson, Jared T., Stebbings, Lucy A., Leroy, Catherine, Edkins, Sarah, Mudie, Laura J., Greenman, Chris D., Jia, Mingming, Latimer, Calli, Teague, Jon W., Lau, King Wai, Burton, John, Quail, Michael A., Swerdlow, Harold, Churcher, Carol, Natrajan, Rachael, Sieuwerts, Anieta M., Martens, John W. M., Silver, Daniel P., Langerød, Anita, Russnes, Hege E. G., Foekens, John A., Reis-Filho, Jorge S., van ’t Veer, Laura, Richardson, Andrea L., Børresen-Dale, Anne-Lise, Campbell, Peter J., Futreal, P. Andrew, Stratton, Michael R.

Volltext

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients von van den Broek, Alexandra J, Schmidt, Marjanka K, van ’t Veer, Laura J, Oldenburg, Hester S A, Rutgers, Emiel J, Russell, Nicola S, Smit, Vincent T. H. B M, Voogd, Adri C, Koppert, Linetta B, Siesling, Sabine, Jobsen, Jan J, Westenend, Pieter J, van Leeuwen, Flora E, Tollenaar, Rob A. E M

Volltext

Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes von Magbanua, Mark Jesus M, Li, Wen, van 't Veer, Laura J

Volltext

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability von Scheepens, Josien C.C., Veer, Laura van ’t, Esserman, Laura, Belkora, Jeff, Mukhtar, Rita A.

Volltext

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial von Parker, Barbara A., Shatsky, Rebecca A., Schwab, Richard B., Wallace, Anne M., Wolf, Denise M., Hirst, Gillian L., Brown-Swigart, Lamorna, Esserman, Laura J., van ’t Veer, Laura J., Ghia, Emanuela M., Yau, Christina, Kipps, Thomas J.

Volltext

RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer von Engebraaten, Olav, Yau, Christina, Berg, Kristian, Borgen, Elin, Garred, Øystein, Berstad, Maria E. B., Fremstedal, Ane S. V., DeMichele, Angela, Veer, Laura van ’t, Esserman, Laura, Weyergang, Anette

Volltext

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers von van den Broek, Alexandra J, van 't Veer, Laura J, Hooning, Maartje J, Cornelissen, Sten, Broeks, Annegien, Rutgers, Emiel J, Smit, Vincent T H B M, Cornelisse, Cees J, van Beek, Mike, Janssen-Heijnen, Maryska L, Seynaeve, Caroline, Westenend, Pieter J, Jobsen, Jan J, Siesling, Sabine, Tollenaar, Rob A E M, van Leeuwen, Flora E, Schmidt, Marjanka K

Volltext

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial von Johansson, Annelie, Dar, Huma, van 't Veer, Laura J, Tobin, Nicholas P, Perez-Tenorio, Gizeh, Nordenskjöld, Anna, Johansson, Ulla, Hartman, Johan, Skoog, Lambert, Yau, Christina, Benz, Christopher C, Esserman, Laura J, Stål, Olle, Nordenskjöld, Bo, Fornander, Tommy, Lindström, Linda S

Volltext

predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer von Knauer, Michael, Mook, Stella, Rutgers, Emiel J. T, Bender, Richard A, Hauptmann, Michael, van de Vijver, Marc J, Koornstra, Rutger H. T, Bueno-de-Mesquita, Jolien M, Linn, Sabine C, van 't Veer, Laura J

Volltext

Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma von Curl, Patti, Vujic, Igor, van 't Veer, Laura J, Ortiz-Urda, Susana, Kahn, James G

Volltext

Converting a breast cancer microarray signature into a high-throughput diagnostic test von Glas, Annuska M, Floore, Arno, Delahaye, Leonie J M J, Witteveen, Anke T, Pover, Rob C F, Bakx, Niels, Lahti-Domenici, Jaana S T, Bruinsma, Tako J, Warmoes, Marc O, Bernards, René, Wessels, Lodewyk F A, Van't Veer, Laura J

Volltext

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk von van ‘t Veer, Laura J., Yau, Christina, Yu, Nancy Y., Benz, Christopher C., Nordenskjöld, Bo, Fornander, Tommy, Stål, Olle, Esserman, Laura J., Lindström, Linda Sofie

Volltext

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer von Lee, Joyce V., Housley, Filomena, Yau, Christina, Nakagawa, Rachel, Winkler, Juliane, Anttila, Johanna M., Munne, Pauliina M., Savelius, Mariel, Houlahan, Kathleen E., Van de Mark, Daniel, Hemmati, Golzar, Hernandez, Grace A., Zhang, Yibing, Samson, Susan, Baas, Carole, Kok, Marleen, Esserman, Laura J., van ‘t Veer, Laura J., Rugo, Hope S., Curtis, Christina, Klefström, Juha, Matloubian, Mehrdad, Goga, Andrei

Volltext